We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+34.53%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$275M
AUM Growth
+$66.7M
Cap. Flow
+$18.8M
Cap. Flow %
6.85%
Top 10 Hldgs %
49.41%
Holding
41
New
4
Increased
18
Reduced
10
Closed
9

Top Buys

Rank Stock Value
1
FLGT icon
Fulgent Genetics
FLGT
+$10.5M
2
XPEV icon
XPeng
XPEV
+$9.68M
3
CMRC
Commerce.com Inc Series 1
CMRC
+$8.87M
4
C icon
Citigroup
C
+$7.2M
5
CVS icon
CVS Health
CVS
+$6.11M

Top Sells

Rank Stock Value
1
APPN icon
Appian
APPN
+$8.27M
2
ANET icon
Arista Networks
ANET
+$6.48M
3
IQ icon
iQIYI
IQ
+$5.78M
4
GSK icon
GSK
GSK
+$5.48M
5
DFS
Discover Financial Services
DFS
+$4.18M

Sector Composition

Rank Sector Weight
1 Financials 36.09%
2 Healthcare 17.18%
3 Technology 15.22%
4 Communication Services 10.55%
5 Consumer Discretionary 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
1
Citigroup
C
$222B
$18M 6.53%
291,358
+141,648
+95% +$7.2M
BIDU icon
2
Baidu
BIDU
$37.7B
$16.6M 6.05%
81,445
-5,947
-7% -$883K
AIG icon
3
American International
AIG
$41.7B
$16.6M 6.04%
438,610
+70,326
+19% +$2.48M
DVN icon
4
Devon Energy
DVN
$52.1B
$13.6M 4.96%
862,790
+426,510
+98% +$5.28M
FLGT icon
5
Fulgent Genetics
FLGT
$470M
$13.1M 4.77%
+251,353
New +$10.5M
DFS
6
DELISTED
Discover Financial Services
DFS
$12.3M 4.47%
135,859
-56,032
-29% -$4.18M
CYBR
7
DELISTED
CyberArk
CYBR
$11.9M 4.34%
73,820
-5,184
-7% -$603K
CB icon
8
Chubb
CB
$135B
$11.5M 4.19%
74,941
+201
+0.3% +$28.2K
XPEV icon
9
XPeng
XPEV
$12.4B
$11.4M 4.13%
+263,549
New +$9.68M
V icon
10
Visa
V
$684B
$10.8M 3.93%
48,486
+1,562
+3% +$320K
MA icon
11
Mastercard
MA
$506B
$10.1M 3.67%
28,308
+1,279
+5% +$425K
RNR icon
12
RenaissanceRe
RNR
$13.3B
$10M 3.64%
60,409
+14,126
+31% +$2.4M
ACGL icon
13
Arch Capital
ACGL
$34.3B
$9.92M 3.61%
275,073
+15,843
+6% +$520K
BMY icon
14
Bristol-Myers Squibb
BMY
$133B
$8.99M 3.27%
145,003
+6,997
+5% +$430K
VMW
15
DELISTED
VMware, Inc
VMW
$8.82M 3.21%
62,876
-1,973
-3% -$283K
HCAT icon
16
Health Catalyst
HCAT
$154M
$8.73M 3.18%
200,646
+3,468
+2% +$128K
VTR icon
17
Ventas
VTR
$48B
$8.57M 3.12%
174,767
-69,769
-29% -$3.23M
BZUN
18
Baozun
BZUN
$167M
$8.49M 3.09%
248,403
+26,608
+12% +$975K
PETQ
19
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$7.96M 2.9%
207,104
-6,528
-3% -$202K
CVS icon
20
CVS Health
CVS
$133B
$7.66M 2.78%
112,139
+94,015
+519% +$6.11M
JD icon
21
JD.com
JD
$44.6B
$7.66M 2.78%
87,124
-607
-0.7% -$50.7K
AMD icon
22
Advanced Micro Devices
AMD
$776B
$7.53M 2.74%
82,067
+573
+0.7% +$49.4K
FUBO icon
23
FuboTV Inc
FUBO
$261M
$7.3M 2.66%
+20,078
New +$5.5M
CMRC
24
Commerce.com Inc Series 1
CMRC
$258M
$7.13M 2.59%
+111,106
New +$8.87M
NTNX icon
25
Nutanix
NTNX
$16B
$6.46M 2.35%
202,620
-38,785
-16% -$1.05M
1
2

Similar funds

CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
PC
Permit Capital West Conshohocken, Pennsylvania $294M AUM 27.9% 1-Year Est. Return
SM
Selkirk Management Chatham, New Jersey $294M AUM 26.84% 1-Year Est. Return
BIC
B&I Capital Zurich, Switzerland $294M AUM 3.09% 1-Year Est. Return
TJHA
Thomas J. Herzfeld Advisors Miami Beach, Florida $294M AUM 2.62% 1-Year Est. Return
FRA
Front Row Advisors Tiburon, California $296M AUM 34.73% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Nepsis Inc's Q4 2020 Portfolio in Review

As of Q4 2020, Nepsis Inc held 41 positions worth $275M, up 32% from $208M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Nepsis Inc deployed $18.8M of net new capital in Q4 2020, opening 4 new positions and adding to 18 existing holdings. Its largest new stake was Fulgent Genetics: 251,353 shares worth $13.1M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was GSK, an estimated $5.48M trimmed.

  • Nepsis Inc's largest Q4 2020 buy was Fulgent Genetics: 251,353 shares worth $13.1M.
  • Nepsis Inc added most to Citigroup in Q4 2020, an estimated $7.2M increase.
  • Nepsis Inc's biggest Q4 2020 reduction was GSK, cutting an estimated $5.48M.
  • Nepsis Inc fully exited Appian in Q4 2020, selling an estimated $8.27M.
  • Nepsis Inc's ten largest holdings make up 49% of its $275M portfolio in Q4 2020.
  • Nepsis Inc opened 4 new positions and closed 9 in Q4 2020.
  • Nepsis Inc's portfolio value rose 32% quarter-over-quarter to $275M.

Based on Nepsis Inc's 13F filing for Q4 2020, filed 22 Jan 2021.